NASDAQ: HALO - Halozyme Therapeutics, Inc.

Yield per half year: +13.85%
Dividend yield: 0.00%
Sector: Healthcare

Forward indicators

Parameter	Grade	Value	Sector average	Difference with sector, %	Average for 5 years	Difference from average, %
P/E	7/10	20.28	57.09	-64.48%	16.5	22.89%
P/E Forward		18.29
P/S		6.89	33.5	-79.44%
P/S Forward		6.49
P/BV		7.73	4.61	67.46%
P/BV Forward		5.89
Ev/Ebitda		15.07	-19.46	-177.46%
Ev/Ebitda Forward		13.48